tiprankstipranks
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market
BCTX
BriaCell Therapeutics
RESEARCH TOOLSreports
Want to see BCTX full AI Analyst Report?

BriaCell Therapeutics (BCTX) Income Statement

323 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q2 2026), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, BriaCell Therapeutics's net income was C$―. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 25Jul 24Jul 23Jul 22Jul 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -147.89KC$ -114.04KC$ -20.49KC$ -19.39KC$ -19.44K
Operating Expenses
C$ 37.59MC$ 46.02KC$ 23.27MC$ 19.58KC$ 6.97M
Depreciation and Amortization
C$ 147.89K-C$ 15.27KC$ 15.27KC$ 15.26K
EBITDA
C$ -36.63MC$ -45.91KC$ -27.23MC$ -34.05MC$ -6.95M
Operating Income
C$ -37.73MC$ -46.02KC$ -23.27MC$ -15.29MC$ -6.97M
Other Income/Expenses
C$ 899.71KC$ 39.21KC$ 2.97MC$ -11.69MC$ -8.54K
Pretax Income
C$ -36.83MC$ -6.81KC$ -20.30MC$ -26.84MC$ -13.82M
Net Income
C$ -36.50MC$ -6.62KC$ -20.30MC$ -11.58MC$ -2.90M
Per Share Metrics
Basic EPS
C$ -86.25C$ -4.28C$ -19.79C$ -25.70C$ -46.73
Diluted EPS
C$ -86.25C$ -4.28C$ -19.79C$ -25.70C$ -46.73
Weighted Average Shares Outstanding
 423.11K 1.10M 1.04M 1.03M 301.31K
Weighted Average Shares Outstanding (Diluted)
 423.11K 1.10M 1.04M 1.03M 301.31K
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History